BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Okamura M, Yoh K, Ojima M, Morito N, Takahashi S. Overexpression of GATA-3 in T cells accelerates dextran sulfate sodium-induced colitis. Exp Anim 2014;63:133-40. [PMID: 24770638 DOI: 10.1538/expanim.63.133] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Giuffrida P, Caprioli F, Facciotti F, Di Sabatino A. The role of interleukin-13 in chronic inflammatory intestinal disorders. Autoimmunity Reviews 2019;18:549-55. [DOI: 10.1016/j.autrev.2019.03.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
2 Zhu J, Yang F, Sang L, Zhai J, Zhang X, Yue D, Li S, Li Y, Lu C, Sun X. IL-33 Aggravates DSS-Induced Acute Colitis in Mouse Colon Lamina Propria by Enhancing Th2 Cell Responses. Mediators Inflamm 2015;2015:913041. [PMID: 26161006 DOI: 10.1155/2015/913041] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
3 Rodrigues VF, Bahia MPS, Cândido NR, Moreira JMP, Oliveira VG, Araújo ES, Rodrigues Oliveira JL, Rezende MC, Correa A Jr, Negrão-Corrêa D. Acute infection with Strongyloides venezuelensis increases intestine production IL-10, reduces Th1/Th2/Th17 induction in colon and attenuates Dextran Sulfate Sodium-induced colitis in BALB/c mice. Cytokine 2018;111:72-83. [PMID: 30118915 DOI: 10.1016/j.cyto.2018.08.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Marafini I, Monteleone G. Inflammatory bowel disease: new therapies from antisense oligonucleotides. Ann Med 2018;50:361-70. [PMID: 29911450 DOI: 10.1080/07853890.2018.1490025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
5 Tsai HF, Wu CS, Chen YL, Liao HJ, Chyuan IT, Hsu PN. Galectin-3 suppresses mucosal inflammation and reduces disease severity in experimental colitis. J Mol Med (Berl). 2016;94:545-556. [PMID: 26631140 DOI: 10.1007/s00109-015-1368-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
6 Zhu JF, Xu Y, Zhao J, Li X, Meng X, Wang TQ, Zou BY, Zhao PY, Liu Q, Lu CL, Zheng FL, Liu HS. IL-33 Protects Mice against DSS-Induced Chronic Colitis by Increasing Both Regulatory B Cell and Regulatory T Cell Responses as Well as Decreasing Th17 Cell Response. J Immunol Res 2018;2018:1827901. [PMID: 30539029 DOI: 10.1155/2018/1827901] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
7 Shajib MS, Baranov A, Khan WI. Diverse Effects of Gut-Derived Serotonin in Intestinal Inflammation. ACS Chem Neurosci 2017;8:920-31. [DOI: 10.1021/acschemneuro.6b00414] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 6.6] [Reference Citation Analysis]
8 Karmele EP, Pasricha TS, Ramalingam TR, Thompson RW, Gieseck RL 3rd, Knilans KJ, Hegen M, Farmer M, Jin F, Kleinman A, Hinds DA, Almeida Pereira T, de Queiroz Prado R, Bing N, Tchistiakova L, Kasaian MT, Wynn TA, Vannella KM; 23andMe Research Team. Anti-IL-13Rα2 therapy promotes recovery in a murine model of inflammatory bowel disease. Mucosal Immunol 2019;12:1174-86. [PMID: 31308480 DOI: 10.1038/s41385-019-0189-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
9 Gamez-Belmonte R, Erkert L, Wirtz S, Becker C. The Regulation of Intestinal Inflammation and Cancer Development by Type 2 Immune Responses. Int J Mol Sci 2020;21:E9772. [PMID: 33371444 DOI: 10.3390/ijms21249772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Chen ML, Sundrud MS. Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2016;22:1157-1167. [PMID: 26863267 DOI: 10.1097/mib.0000000000000714] [Cited by in Crossref: 57] [Cited by in F6Publishing: 37] [Article Influence: 11.4] [Reference Citation Analysis]
11 Bilsborough J, Fiorino MF, Henkle BW. Select animal models of colitis and their value in predicting clinical efficacy of biological therapies in ulcerative colitis. Expert Opin Drug Discov 2021;16:567-77. [PMID: 33245673 DOI: 10.1080/17460441.2021.1851185] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Li M, Liu X, Liu Z, Hong J, Liu J, Zhou C, Hu T, Xiao X, Ran P, Zheng P, Liu Z, Yang P. Bcl2L12 Contributes to Th2-Biased Inflammation in the Intestinal Mucosa by Regulating CD4 + T Cell Activities. J I 2018;201:725-33. [DOI: 10.4049/jimmunol.1800139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
13 Bamias G, Cominelli F. Role of type 2 immunity in intestinal inflammation. Curr Opin Gastroenterol. 2015;31:471-476. [PMID: 26376478 DOI: 10.1097/mog.0000000000000212] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
14 Zundler S, Neurath MF. Pathogenic T cell subsets in allergic and chronic inflammatory bowel disorders. Immunol Rev 2017;278:263-76. [DOI: 10.1111/imr.12544] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
15 Imam T, Park S, Kaplan MH, Olson MR. Effector T Helper Cell Subsets in Inflammatory Bowel Diseases. Front Immunol 2018;9:1212. [PMID: 29910812 DOI: 10.3389/fimmu.2018.01212] [Cited by in Crossref: 76] [Cited by in F6Publishing: 69] [Article Influence: 19.0] [Reference Citation Analysis]
16 Mirlekar B. Co-expression of master transcription factors determines CD4+ T cell plasticity and functions in auto-inflammatory diseases. Immunol Lett 2020;222:58-66. [PMID: 32220615 DOI: 10.1016/j.imlet.2020.03.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
17 Shang J, Li L, Wang X, Pan H, Liu S, He R, Li J, Zhao Q. Disruption of Tumor Necrosis Factor Receptor-Associated Factor 5 Exacerbates Murine Experimental Colitis via Regulating T Helper Cell-Mediated Inflammation. Mediators Inflamm. 2016;2016:9453745. [PMID: 27110068 DOI: 10.1155/2016/9453745] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
18 Chen ML, Sundrud MS. Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2016;22:1157-1167. [PMID: 26863267 DOI: 10.1097/mib.000000 0000000714] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Schirmer B, Bringmann L, Seifert R, Neumann D. In vivo Evidence for Partial Activation of Eosinophils via the Histamine H4-Receptor: Adoptive Transfer Experiments Using Eosinophils From H4R-/- and H4R+/+ Mice. Front Immunol 2018;9:2119. [PMID: 30319608 DOI: 10.3389/fimmu.2018.02119] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
20 Popp V, Gerlach K, Mott S, Turowska A, Garn H, Atreya R, Lehr HA, Ho IC, Renz H, Weigmann B, Neurath MF. Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice. Gastroenterology. 2017;152:176-192.e5. [PMID: 27639807 DOI: 10.1053/j.gastro.2016.09.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
21 Steury MD, Kang HJ, Lee T, Lucas PC, McCabe LR, Parameswaran N. G protein-coupled receptor kinase-2-deficient mice are protected from dextran sodium sulfate-induced acute colitis. Physiol Genomics 2018;50:407-15. [PMID: 29570431 DOI: 10.1152/physiolgenomics.00006.2018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Yadav V, Varum F, Bravo R, Furrer E, Bojic D, Basit AW. Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets. Transl Res 2016;176:38-68. [PMID: 27220087 DOI: 10.1016/j.trsl.2016.04.009] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 14.2] [Reference Citation Analysis]
23 Mao YM, Zhao CN, Leng J, Leng RX, Ye DQ, Zheng SG, Pan HF. Interleukin-13: A promising therapeutic target for autoimmune disease. Cytokine Growth Factor Rev 2019;45:9-23. [PMID: 30581068 DOI: 10.1016/j.cytogfr.2018.12.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]